|
||||||||||||||||||||||||||||||||
 |
The Speakers
| Shacker Mourad | Director, CI |
AstraZeneca |
| Wayne Rosenkrans | Director, Scientific and Medical Strategy, External Scientific Affairs |
AstraZeneca |
| Thomas Han | Director, Strategic Marketing | Biovail |
| Richard Withers | Managing Partner | Deallus |
| Richard Walker | Vice President | Denodo |
| Leonard Fuld | President | Fuld & Co |
| Michael Sandman | Senior Vice President | Fuld & Co |
| Nicholas Osgood | Manager, Associate Market Planning | Genentech |
| Kat Lynch | Vice President, CI | Genzyme |
| Neil Mahoney | President | Global Business Management Concepts |
| Former Vice President, CI | Novartis | |
| Jonathan Peck | President, Institute for Alternative Futures | IAF |
| Rafaat Rahmani | Founder and President | Lifescience Dynamics |
| Jeffrey Berk | President | MedPredict |
| Dr. Daniel Pascheles | Vice President, Corporate Development | Merck&Co |
| Debbie Allison | Senior Director, Global CI | Merck&Co |
| Chris Pounds | Associate Director, Commercial Analytics | Myriad Pharmaceuticals |
| David Stefanoni | Director, BI; Director, Business Excellence Analytics & Planning | Sanofi-aventis |
| Dr. Thani Jambulingam | Chair and Associate Professor, Pharmaceutical Strategy & Marketing | St. Joseph’s University |
| Craig McHenry | Senior Director, Competitor Insights, Customer & Market Insights | Wyeth |
| Michael Fuller | Analyst | Nerac |
| Irene Zajac | Analyst | Nerac |
